IL5 and asthma: Thus, given the mixed outcomes of targeting IL-5/eosinophils and the potential for the involvement of other inflammatory immune cells in asthma pathogenesis, there remains an unmet need for better asthma treatments, particularly in terms of exacerbation prevention (30).